AZ Macclesfield site

AstraZeneca invests £75m to future-proof production facilities

pharmafile | December 15, 2015 | News story | Manufacturing and Production AstraZeneca, manufacturing, production 

AstraZeneca says it will invest £75m to future-proof a key production facility in Macclesfield, Cheshire.

The upgrade to the 48-year-old site will add a state of the art packing and warehouse facility to the North-West England location, which currently employs some 3,500 people. Although no new employment opportunities are expected to be created, the investment is expected to secure the existing jobs at the plant.

The new buildings at AZ’s second largest facility will replace an existing warehouse – which is currently being demolished – and will include packing lines for tablets and capsules, as well as an automated warehouse. Construction work is expected to begin early in the New Year, and follows the recent work on a new sterile production facility, also at the Macclesfield site.

AstraZeneca’s latest investment comes two years after the company axed 1,600 jobs at its Alderley Park complex, after moving its R&D operations to Cambridge.

The pharmaceutical giant was yesterday reported to be chasing a £3 billion-plus purchase of privately-held cancer drug developer Acerta Pharma, as the Anglo-Swedish company seeks to add new cancer drugs to its portfolio, including Acerta’s lead candidate acalabrutinib.

Joel Levy

Related Content

ANGLE signs commercial agreement with AstraZeneca

ANGLE has announced that it has signed a supplier agreement with AstraZeneca for the development …

Ardena announces €20m expansion following first GMP approval

Ardena has announced that it has received Good Manufacturing Practice (GMP) approval from the Dutch …

AstraZeneca shares results for Imfinzi in phase 3 trial for small cell lung cancer

AstraZeneca has announced positive high-level results from the phase 3 ADRIATIC trial, which demonstrated that …

Latest content